LNTH
Price:
$90.52
Market Cap:
$6.29B
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also of...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-06-25
Stock Exchange
NASDAQ
Ticker
LNTH
According to Lantheus Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.05B. This represents a change of 15.63% compared to the average of 5.23B of the last 4 quarters.
The mean historical Enterprise Value of Lantheus Holdings, Inc. over the last ten years is 1.47B. The current 6.05B Enterprise Value has changed 41.07% with respect to the historical average. Over the past ten years (40 quarters), LNTH's Enterprise Value was at its highest in in the September 2024 quarter at 7.38B. The Enterprise Value was at its lowest in in the March 2016 quarter at 371.51M.
Average
1.47B
Median
884.93M
Minimum
407.52M
Maximum
4.14B
Discovering the peaks and valleys of Lantheus Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 133.12%
Maximum Annual Enterprise Value = 4.14B
Minimum Annual Increase = -21.25%
Minimum Annual Enterprise Value = 407.52M
Year | Enterprise Value | Change |
---|---|---|
2023 | 4.14B | 13.85% |
2022 | 3.63B | 79.30% |
2021 | 2.03B | 133.12% |
2020 | 869.06M | -3.52% |
2019 | 900.79M | 19.88% |
2018 | 751.40M | -21.25% |
2017 | 954.15M | 89.88% |
2016 | 502.51M | 23.31% |
2015 | 407.52M | -19.79% |
2014 | 508.08M | -0.55% |
The current Enterprise Value of Lantheus Holdings, Inc. (LNTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.26B
5-year avg
2.31B
10-year avg
1.47B
Lantheus Holdings, Inc.’s Enterprise Value is less than Neurocrine Biosciences, Inc. (12.62B), greater than Deciphera Pharmaceuticals, Inc. (2.15B), greater than Ironwood Pharmaceuticals, Inc. (677.16M), greater than Alkermes plc (4.63B), greater than Avadel Pharmaceuticals plc (1.10B), less than ANI Pharmaceuticals, Inc. (0), greater than Dr. Reddy's Laboratories Limited (1.68B), less than Collegium Pharmaceutical, Inc. (1.04T), greater than Pacira BioSciences, Inc. (1.80B), greater than Alvotech (1.21B), greater than Catalent, Inc. (4.68B), less than Amphastar Pharmaceuticals, Inc. (15.68B), greater than Journey Medical Corporation (2.62B), greater than Aquestive Therapeutics, Inc. (109.54M), greater than Dynavax Technologies Corporation (374.75M), greater than null (1.76B),
Company | Enterprise Value | Market cap |
---|---|---|
12.62B | $12.72B | |
2.15B | $2.21B | |
677.16M | $550.50M | |
4.63B | $4.66B | |
1.10B | $1.12B | |
0 | $1.20B | |
1.68B | $11.84B | |
1.04T | $966.22M | |
1.80B | $810.34M | |
1.21B | $3.35B | |
4.68B | $11.07B | |
15.68B | $2.19B | |
2.62B | $112.18M | |
109.54M | $415.77M | |
374.75M | $1.63B | |
1.76B | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lantheus Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lantheus Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Lantheus Holdings, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Lantheus Holdings, Inc. (LNTH)?
What is the 3-year average Enterprise Value for Lantheus Holdings, Inc. (LNTH)?
What is the 5-year average Enterprise Value for Lantheus Holdings, Inc. (LNTH)?
How does the current Enterprise Value for Lantheus Holdings, Inc. (LNTH) compare to its historical average?